Atlas Trials

A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients

Clinical trial NCT04521868 · COMPLETED

Trial details

NCT number
NCT04521868
Sponsor
Central South University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2020-08-31
Primary completion
2022-08-12
Enrollment
125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.